SF
BHVN

Synovus Financial’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Synovus Financial’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-108
Closed -$8K – 1628
2020
Q2 		$8K Hold
108
– – ﹤0.01% 1259
2020
Q1 		$4K Hold
108
– – ﹤0.01% 1848
2019
Q4 		$6K Hold
108
– – ﹤0.01% 1300
2019
Q3 		$5K Hold
108
– – ﹤0.01% 1307
2019
Q2 		$5K Hold
108
– – ﹤0.01% 1238
2019
Q1 		$6K Hold
108
– – ﹤0.01% 1210
2018
Q4 		$4K Hold
108
– – ﹤0.01% 1258
2018
Q3 		$4K Buy
+108
New +$3.97K ﹤0.01% 1286

Other funds holding BHVN

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Synovus Financial's BHVN Position: Q3 2020 in Review

Synovus Financial sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2020, closing a stake of 108 shares — an estimated $8K sold.

Synovus Financial first reported a position in BHVN in Q3 2018 and held it in 8 quarters. The position peaked at $8K in Q2 2020. 215 funds tracked by Wall St. Rank hold BHVN as of Q3 2020.

  • Synovus Financial reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 108 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2020, an estimated $8K.
  • Synovus Financial first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2018 and held it in 8 quarters.
  • Synovus Financial's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $8K in Q2 2020.
  • 215 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.